Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Eutro ( EUTO ) -- Ignore unavailable to you. Want to Upgrade?

To: Makedacash who wrote (4499)	3/15/1998 10:39:00 PM
From: Ricardo A. Biondi	Read Replies (1) \| Respond to of 12043

To ALL: Take a look at this eutro.com Eutro Homepage!!! Best Regards, R.B.

To: Makedacash who wrote (4499)	3/15/1998 10:48:00 PM
From: Ricardo A. Biondi	Read Replies (1) \| Respond to of 12043

Summary Overview Eutro Group Holding, Inc. (The "Company" or "Eutro"), was organized under the laws of the state of Florida in September 1991, following the reverse acquisition with Bio-Analytic Laboratories, Inc. a Florida corporation. Bio is engaged in the manufacture and sale of chemical solutions (or "reagents"), disposable accessories necessary to perform in-vitro tests of blood, urine, or other body fluids and medical diagnostic testing instrumentation used in conjunction with the subsidiary's test kit. Eutro Group Holding, Inc. is involved in providing capital to bring new products to market, technical assistance to develop marketing and sales opportunities and furnishes a strong management core, with over 70 years experience in securities, investment banking and management consulting. Eutro's newest endeavor is to assist companies to obtain the proper posture to raise capital necessary for these companies to become successful. In addition, Eutro acts as management and financial consultants. Eutro maintains an office at 1070 E. Indiantown Road, Suite 208,Jupiter, FL 33477. Telephone (561) 575-3520. Fax (561) 575-0953. Email eutrogroup@postoffice.worldnet.att.net. Eutro Group Holding, Inc.'s business, directly and through its subsidiary, is centered on their core services: producing, selling and distributing of a wide assortment of health products to a broad array of medical institutions and personnel within the industry promoting health and wellness products to consumers, and providing professional management advice. Since the Company's business began in 1971, it has focused on providing hospital and clinical laboratories, and physicians offices with the highest quality in-vitro diagnostic reagent test kits supporting instrumentation, and disposable accessories. As a result, product performance has been outstanding and the Company has an established domestic and international market for its unitized test kit. During Bio-Analytic Laboratories, Inc. (Bio) third decade of operations, even with meticulous quality controls and a history of satisfied customers, began to feel the effects of an evolving diagnostic industry, and consolidations by overseas manufacturers who assumed ownership of major U.S. companies. In spite of their distributor network and reliance on product performance to maintain a competitive edge, this business found it increasingly difficult to compete. The aim of Bio is to exist and prosper in its environment. The companies that will prosper are those which will utilize the classic method of acquisition, to engage in limited vertical integration. It is the intention of Bio to enter into an acquisition program utilizing capital stock and limited amounts of cash. Bio is now ready to become an effective company which, if it can be joined with other companies in the medical field, can become a very significant asset for Eutro. Eutro was originally conceived as a holding company which would have as its primary activity the maximization of the value of its security portfolio. Its modus operandi was to have been proactive investment banking, meaning that it would actively seek to implement its investment concepts rather than simply wait for potential clients to approach it. While there may be a mega difference in size, the basic concept is similar to ~hat of Berkshire Hathaway. Simply stated, Eutro will be compensated in three possible ways for the services it renders to its clients. First, is a cash payment to cover actual expenses and leave a profit. Second, is a block of the clients common shares. Third is the possibility of an ongoing relationship with the client as financial consultant/advisor. The above described changes and operations will benefit the Eutro stockholder in the following ways. The cash portion of the fees charged to its clients will leave sufficient money to enable Eutro to expand its operations and thus attract larger clients. Next, the appreciation in the common stock portion of the fees it receives will increase the book value of the Eutro common stock. Eutro stockholders will benefit from the growth of Eutro, but will also share in the equity position of each of the companies from which Eutro receives stock . Eutro will be the stepping stone by which the client companies become financially sound and important in their industry.